Related Articles
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer
Potential of endogenous estrogen receptor β to influence the selective ER modulator ERβ complex
An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade
Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression
Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors α and β